Skip to main content
. 2009 Dec;11(8):645–655. doi: 10.1111/j.1477-2574.2009.00107.x

Table 1.

Demographics and co-morbidities of patients who did and did not receive chemotherapy within 30 days of liver resection

No chemotherapy Chemotherapy P-value
n= 2147 (%) n= 184 (%)
Age, years 58.4 ± 13.7 57.3 ± 10.6 0.30
Men 1045 (49) 104 (57) 0.04
Race 0.40
Indian/Alaskan 9 (0.4) 1 (0.5)
Asian 89 (4) 5 (3)
Black/Black Hispanic 170 (8) 10 (5)
Hispanic/Hispanic unknown 73 (3) 2 (1)
White 1650 (77) 156 (85)
Unknown 156 (7) 10 (5)
Current smoker 328 (15) 28 (15) 0.98
>2 alcoholic drinks/day 61 (3) 6 (3) 0.74
Body mass index, median 26.9 27.2 0.15
ASA physical status classification 0.72
1 35 (1.6) 3 (1.6)
2 729 (34) 58 (31.5)
3 1272 (59) 117 (64)
4 110 (0.5) 6 (3)
5 1 (0.04) 0 (0)
Co-morbidities
Diabetes mellitus 0.07
No 1825 (85) 168 (91)
Oral hypoglycaemic treatment 228 (11) 11 (6)
Insulin therapy 94 (4) 5 (3)
History of severe chronic obstructive pulmonary disease 67 (3) 3 (2) 0.26
Congestive heart failure within the 30 days prior to surgery 8 (0.4) 1 (0.5) 0.72
Hypertension requiring medication 988 (46) 74 (40) 0.13
Loss of >10% of body weight in previous 6 months 114 (5) 12 (6.5) 0.49
Transfusion >5 units pRBC preoperatively 6 (0.3) 1 (0.5) 0.44
Steroid use for chronic condition 40 (2) 4 (2) 0.77
Ascites 31 (1) 2 (1) 0.69
Disseminated cancer 818 (38) 147 (77) <0.001
Radiotherapy for malignancy in last 90 days 16 (0.7) 11 (6) <0.001

ASA, American Society of Anesthesiologists; pRBC, packed red blood cells

P-values shown in bold are significant at P < 0.05